178 related articles for article (PubMed ID: 36755219)
1. Association of circulating MtDNA with CVD in hemodialysis patients and in vitro effect of exogenous MtDNA on cardiac microvascular inflammation.
Fan Z; Feng Y; Zang L; Guo Y; Zhong XY
BMC Cardiovasc Disord; 2023 Feb; 23(1):74. PubMed ID: 36755219
[TBL] [Abstract][Full Text] [Related]
2. Circulatory mitochondrial DNA is a pro-inflammatory agent in maintenance hemodialysis patients.
Cao H; Ye H; Sun Z; Shen X; Song Z; Wu X; He W; Dai C; Yang J
PLoS One; 2014; 9(12):e113179. PubMed ID: 25485699
[TBL] [Abstract][Full Text] [Related]
3. Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events.
Papayianni A; Alexopoulos E; Giamalis P; Gionanlis L; Belechri AM; Koukoudis P; Memmos D
Nephrol Dial Transplant; 2002 Mar; 17(3):435-41. PubMed ID: 11865089
[TBL] [Abstract][Full Text] [Related]
4. Increased level of free-circulating MtDNA in maintenance hemodialysis patients: Possible role in systemic inflammation.
Zhong XY; Guo Y; Fan Z
J Clin Lab Anal; 2022 Jul; 36(7):e24558. PubMed ID: 35708020
[TBL] [Abstract][Full Text] [Related]
5. [Role of adenosine A2b receptors in pulmonary microvascular endothelial inflammation induced by lipopolysaccharide].
Guo X; An Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Dec; 31(12):1485-1490. PubMed ID: 32029034
[TBL] [Abstract][Full Text] [Related]
6. Relationship between chronic periodontitis and inflammatory cytokines in patients undergoing maintenance hemodialysis.
Lu H; Wu H; Yang Y; Feng X; Ma X; Xie Y; Xie D; Wang W; Lo ECM; Ye W
Clin Oral Investig; 2022 Nov; 26(11):6699-6709. PubMed ID: 35861756
[TBL] [Abstract][Full Text] [Related]
7. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
Koenig W
Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
[TBL] [Abstract][Full Text] [Related]
8. Circulating Cell-Free Mitochondrial DNA: A Potential Blood-Based Biomarker for Sarcopenia in Patients Undergoing Maintenance Hemodialysis.
Fan Z; Guo Y; Zhong XY
Med Sci Monit; 2022 Mar; 28():e934679. PubMed ID: 35263317
[TBL] [Abstract][Full Text] [Related]
9. Expanded Hemodialysis Therapy Ameliorates Uremia-Induced Systemic Microinflammation and Endothelial Dysfunction by Modulating VEGF, TNF-α and AP-1 Signaling.
Catar R; Moll G; Kamhieh-Milz J; Luecht C; Chen L; Zhao H; Ernst L; Willy K; Girndt M; Fiedler R; Witowski J; Morawietz H; Ringdén O; Dragun D; Eckardt KU; Schindler R; Zickler D
Front Immunol; 2021; 12():774052. PubMed ID: 34858433
[TBL] [Abstract][Full Text] [Related]
10. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in patients on hemodialysis.
Yano H; Horinaka S; Yagi H; Ishimitsu T
Heart Vessels; 2013 May; 28(3):308-15. PubMed ID: 22526379
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of circulating oxidized mitochondrial DNA contribute to chronic inflammation in metabolic syndrome, and MitoQ-based antioxidant therapy alleviates this DNA-induced inflammation.
Ye W; Wen C; Zeng A; Hu X
Mol Cell Endocrinol; 2023 Jan; 560():111812. PubMed ID: 36334615
[TBL] [Abstract][Full Text] [Related]
12. Expanded Hemodialysis ameliorates uremia-induced impairment of vasculoprotective KLF2 and concomitant proinflammatory priming of endothelial cells through an ERK/AP1/cFOS-dependent mechanism.
Zhao H; Wu D; Gyamfi MA; Wang P; Luecht C; Pfefferkorn AM; Ashraf MI; Kamhieh-Milz J; Witowski J; Dragun D; Budde K; Schindler R; Zickler D; Moll G; Catar R
Front Immunol; 2023; 14():1209464. PubMed ID: 37795100
[TBL] [Abstract][Full Text] [Related]
13. Endocan--the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease.
Pawlak K; Mysliwiec M; Pawlak D
Clin Biochem; 2015 Apr; 48(6):425-30. PubMed ID: 25617664
[TBL] [Abstract][Full Text] [Related]
14. Relationship of Serum Soluble Klotho Levels and Echocardiographic Parameters in Patients on Maintenance Hemodialysis.
Zhang AH; Guo WK; Yu L; Liu WH
Kidney Blood Press Res; 2019; 44(3):396-404. PubMed ID: 31079116
[TBL] [Abstract][Full Text] [Related]
15. Microinflammation is involved in the dysfunction of arteriovenous fistula in patients with maintenance hemodialysis.
Liu BC; Li L; Gao M; Wang YL; Yu JR
Chin Med J (Engl); 2008 Nov; 121(21):2157-61. PubMed ID: 19080177
[TBL] [Abstract][Full Text] [Related]
16. Serum 25(OH)D Concentration and Cardiovascular Disease Risk Markers Among Middle-Aged Healthy and Type 2 Diabetic Subjects.
Dhas Y; Banerjee J; Damle G; Mishra N
Horm Metab Res; 2021 Oct; 53(10):676-682. PubMed ID: 34433211
[TBL] [Abstract][Full Text] [Related]
17. Sulodexide reduces the inflammatory reaction and senescence of endothelial cells in conditions involving chronic venous disease.
Urbanek T; Krasinski Z; Sumińska-Jasińska K; Baum E; Borej-Nowicka G; Begier-Krasińska B; Bręborowicz A
Int Angiol; 2016 Apr; 35(2):140-7. PubMed ID: 26868135
[TBL] [Abstract][Full Text] [Related]
18. Relationship between serum hepcidin levels and cardiovascular disease in patients with maintenance hemodialysis.
Xu Y; Wang Y; Hu H; Li J; Tian T
Physiol Int; 2020 Dec; 107(4):491-500. PubMed ID: 33355540
[TBL] [Abstract][Full Text] [Related]
19. Association of classical and related inflammatory markers with high-sensitivity C-reactive protein in healthy individuals: results from the Stanislas cohort.
Berrahmoune H; Herbeth B; Lamont JV; Lambert D; Blankenberg S; Tiret L; FitzGerald PS; Siest G; Visvikis-Siest S
Clin Chem Lab Med; 2007; 45(10):1339-46. PubMed ID: 17727316
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress influences CC-chemokine levels in hemodialyzed patients.
Pawlak K; Pawlak D; Mysliwiec M
Nephron Physiol; 2004; 96(4):p105-12. PubMed ID: 15122056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
